Cann Group Limited (CAN:ASX)

29.5¢

right-arrow Created with Sketch. 0 (0%)
MCAP $102.9M
Last trade 15.18pm 28/10/2021 20mins delayed

Latest Announcements

25/10/2021CANCann Group Limited
22/10/2021CANCann Group Limited
21/10/2021 Price SensitivePSCANCann Group Limited
21/10/2021 Price SensitivePSCANCann Group Limited
18/10/2021CANCann Group Limited
08/10/2021CANCann Group Limited
01/10/2021CANCann Group Limited
30/09/2021CANCann Group Limited

Company Overview

Cann Group Limited is an Australia-based company, which is focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. The company has established research and cultivation facilities in Melbourne and is developing a cultivation facility near Mildura, Victoria. It focuses on developing and supplying cannabis, cannabis resin and medicinal cannabis products into the Australian market. The Company has a cannabis research license and cannabis cultivation license. The cannabis cultivation license allows the Company to produce Australian grown material that can be prescribed for patient use. It focuses on plant genetics, breeding, cultivation, extraction, analysis and production techniques to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions.

CAN in the news

Cann Group (CAN) and Emyria (EMD) mutually agree to drop a deal…
Cann Group (CAN) is looking to raise $20 million in extra cash…
Cann Group (CAN) locks its shares in a trading halt after announcing…
Cann Group (CAN) receives $1.2 million in court proceedings as the company…

Search Previous Announcements